1. India Stocks

  2. •

    Consumer Cyclical

  3. •

    Apparel - Footwear & Accessories
Relaxo Footwears Limited

Relaxo Footwears Limited

RELAXO.BO
Relaxo Footwears LimitedIN flagBombay Stock Exchange
386.40
INR
+1.30
- -
96.21BMarket Cap
Relaxo Footwears Limited
RELAXO.BO
(Bombay Stock Exchange)

Recent

price

386.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
28.81
36.02
42.07
50.51
123.39
71.31
67.92
80.34
91.81
96.43
94.45
106.73
111.04
116.19
112.02
- -
108.49
Revenue per Share
1.11
1.66
1.87
2.73
8.59
5.01
4.99
6.7
7.07
9.12
11.74
9.36
6.21
8.05
6.84
- -
7.2
Basic EPS, GAAP
-0.79
1
-1.24
2.24
-1.98
1.03
3.74
1.88
1.25
8.17
15.7
-3.36
8.63
-0.57
11.65
- -
- -
Free Cash Flow per Basic Share
0.09
0.06
0.09
0.12
0.29
0.3
0.36
0.6
0.88
2.59
- -
2.5
2.5
2.5
3
- -
- -
Dividend per Share
5.56
0.5
0.38
0.47
0.59
0.61
1.03
1.92
2.17
3.07
2.73
3.55
4.24
4.77
1
- -
1
Book Value per Share
5.44
7.03
8.71
11.26
30.18
17.16
22.68
29.32
42.59
49.55
61.74
69.5
73.24
79.44
83.7
- -
88.22
Tangible Book Value per Share
240
240
240
240
120
240
240
240
248
248
248
249
249
249
249
- -
249
Basic Weighted Avg Shares
6,916
8,647
10,098
12,123
14,808
17,118
16,312
19,317
22,769
23,929
23,456
26,533
27,641
28,936
27,896
27,022
27,022
Sales/Revenue/Turnover
7.44
8.35
8.35
9.63
10.9
11.32
11.56
12.88
11.76
12.67
16.63
11.39
7.81
8.95
8.01
8.02
8.02
Operating Margin (%)
210
231
255
312
399
471
515
543
624
1,094
1,100
1,135
1,251
1,475
1,584
1,572
1,572
Depreciation Expense
267
399
448
656
1,030
1,203
1,200
1,611
1,754
2,262
2,916
2,327
1,545
2,005
1,703
1,793
1,793
Net Income, GAAP
24.85
25.39
33.8
31.29
27.76
32.27
32.62
33.88
34.53
22.44
25.46
25.09
26.45
25.55
25.9
25.76
25.76
Effective Tax Rate (%)
3.86
4.62
4.44
5.41
6.96
7.03
7.35
8.34
7.71
9.45
12.43
8.77
5.59
6.93
6.11
6.63
6.63
Profit Margin (%)
-250
-113
319
224
606
570
869
1,469
2,641
3,779
6,308
7,259
7,230
7,269
7,838
6,809
6,809
Working Capital
964
925
1,502
1,143
1,445
1,130
709
393
- -
1,198
1,152
1,228
1,283
1,504
1,686
1,877
1,877
LT Debt
1,346
1,724
2,144
2,766
3,678
4,800
6,064
7,612
11,051
12,724
15,724
17,601
18,550
20,011
20,981
22,064
22,064
Total Equity
14.11
16.42
13.49
16.6
20.3
18.66
15.97
18.38
15.76
17.14
17.92
12.09
7.85
8.94
7.26
6.77
6.77
Return on Invested Capital (%)
17.5
22.46
26.73
36.5
50.97
54.57
57.12
82.73
98.56
117.19
133.84
102.99
63.36
72.22
66.16
78.9
64.07
Return on Capital (%)
38.32
54.84
422.51
645.5
1,126.81
1,107.09
607.5
454.55
351.76
348.64
405.62
298.38
159.4
178.75
237.13
720.25
218.21
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
494
- -
450
LT Borrowings
- -
- -
- -
LT Finance Leases
1,661
- -
1,877
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
249
- -
249
Market Capitalization
111,265
100,676
59,256

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
11,884
- -
11,935
Cash, Cash Equivalents & STI
2,549
- -
2,284
Accounts Receivable, Net
2,732
- -
2,989
Inventories
5,938
- -
5,567
Total Current Liabilities
5,518
- -
5,126
Payables & Accruals
- -
- -
- -
ST Debt
494
- -
450
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.1%
7.04%
5.16%
Free Cash Flow
-191.72%
-549.22%
-27.24%
Net Income, GAAP
6.7%
-6.76%
5.25%
Sales/Revenue/Turnover
5%
3.05%
-3.13%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,388
7,153
7,127
7,268
28,936
2025
7,482
6,794
6,669
6,952
27,896
2026
6,545
6,285
6,680
7,511
27,022

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.26
1.78
1.55
- -
8.05
2025
1.78
1.48
1.32
2.26
6.84
2026
1.96
1.46
1.06
2.72
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2.5
2025
- -
- -
- -
- -
3
2026
- -
- -
- -
- -
- -
Similar Companies
TATA Health International Holdings Limited (1255.HK)
McRae Industries, Inc. (MCRAB)
Boss Holdings, Inc. (BSHI)
In the F CO.,LTD. (014990.KS)
Gretex Industries Ltd. (GRETEX.NS)
Mirza International Limited (MIRZAINT.NS)
Business
Relaxo Footwears Limited, India's largest footwear manufacturer by volume, engages in the production, marketing and distribution of mass-market footwear for men, women and children. The company offers slippers including hawai rubber, ethylene vinyl acetate and polyurethane variants; sandals and floaters; sports shoes; casual shoes; running shoes; and athleisure footwear, sold primarily under its flagship brands Relaxo, Sparx, Flite and Bahamas, as well as BOSTON, Mary Jane, Casualz and KidsFun. Relaxo operates eight manufacturing facilities across Haryana, Rajasthan, Uttarakhand and Himachal Pradesh with an aggregate capacity exceeding 30 crore pairs annually; it maintains a pan-India distribution network spanning over 100,000 retail outlets and exports to more than 30 countries including recent market entries in the Philippines and Morocco. Incorporated in 1976 and listed on the National Stock Exchange and BSE since 1984, the company maintains its headquarters in New Delhi. Recent strategic developments include the acquisition of a 30-acre land parcel in Bhiwadi, Rajasthan, for Rs 135 crore in December 2023 to expand manufacturing capacity; a Rs 150 crore investment plan for a new open footwear facility in the current fiscal; launches of premium polyurethane products under the Flite brand and eco-friendly lines; and expansion of direct-to-consumer platforms alongside e-commerce partnerships that boosted online sales. In Q2 FY26, Relaxo reported revenue of Rs 629 crore amid mass-market softness and GST transitions, with stable EBITDA margins at 12.9% and improved PAT margins at 5.8%, while positioning for recovery via GST 2.0 benefits, premiumization and 50 new retail outlets including exclusive Sparx stores.